title: Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology.
abstract: A small percentage of Lyme patients develop mild to moderate encephalopathic symptoms months to years after diagnosis and treatment. Their symptoms typically include fatigue, memory loss, sleep disturbance, and depression. However, the etiology of this syndrome remains controversial. It is generally thought that Lyme patients with abnormal cerebral spinal fluid (CSF) have a neurological basis to their illness. To further examine this question, we compared Lyme patients with evidence of abnormal CSF, intrathecal antibody to Borrelia burgdorferi, elevated protein, or a positive polymerase chain reaction for B. burgdorferi DNA (n = 14); Lyme patients with normal CSF (n = 18); and healthy controls (n = 15) on a battery of neuropsychological and personality tests. Although both Lyme groups reported memory problems, only the Lyme group with abnormal CSF had measurable memory deficits. Both Lyme groups had higher depression scores than the normal control group, although depression was not correlated with memory scores. It appears that Lyme patients with abnormal CSF may have a neurological basis to their illness, whereas affective symptoms, common to many chronic disorders, may predispose other Lyme patients to the perception of cognitive dysfunction.
authors.affiliation: Department of Neurology, Tufts University School of Medicine, Boston, Massachusetts, USA.
authors.forename: R F
authors.initials: RF
authors.lastname: Kaplan
authors.forename: L
authors.initials: L
authors.lastname: Jones-Woodward
authors.forename: K
authors.initials: K
authors.lastname: Workman
authors.forename: A C
authors.initials: AC
authors.lastname: Steere
authors.forename: E L
authors.initials: EL
authors.lastname: Logigian
authors.forename: M E
authors.initials: ME
authors.lastname: Meadows
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000175:diagnosis / Q000209:etiology; D015748:Borrelia burgdorferi Group / Q000276:immunology; D001927:Brain Diseases / Q000134:cerebrospinal fluid* / Q000209:etiology*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology*; D003866:Depressive Disorder / Q000175:diagnosis / Q000209:etiology; D005260:Female; D006801:Humans; D008193:Lyme Disease / Q000150:complications* / Q000276:immunology / Q000523:psychology; D008297:Male; D009483:Neuropsychological Tests; D016133:Polymerase Chain Reaction; D012720:Severity of Illness Index
chemical_list: D002556:Cerebrospinal Fluid Proteins